In win for Abbey Labs, Elanco’s animal drug patent thrown out for lack of invention
IP Australia has refused to register a patent acquired by Elanco Australasia from Bayer covering a lice treatment, after amendments failed to address findings that the patent lacked an inventive step.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
